The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome

Heart Failure Reviews

Volumn 16, Issue 6, 2011, Pages 609-614

  Silverberg, Donald S ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anemia; Cardio renal syndrome; Erythropoietin; Heart failure; Iron; Renal failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; BETA NATRIURETIC PEPTIDE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; NATRIURETIC FACTOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; CARDIO RENAL ANEMIA SYNDROME; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL CLASSIFICATION; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EXERCISE; FERRITIN BLOOD LEVEL; HEART FUNCTION; HEMATOLOGICAL PARAMETERS; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERVOLEMIA; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FUNCTION; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; PROTEIN SYNTHESIS; QUALITY OF LIFE; THROMBOCYTOSIS; TRANSFERRIN SATURATION; UNSPECIFIED SIDE EFFECT;

ANEMIA; BONE MARROW; CARDIOVASCULAR SYSTEM; CLINICAL TRIALS AS TOPIC; ERYTHROPOIETIN; HEART FAILURE; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; KIDNEY; OUTCOME ASSESSMENT (HEALTH CARE); RENAL INSUFFICIENCY, CHRONIC; SYNDROME; TRACE ELEMENTS;

EID: 80052437806     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-010-9194-2     Document Type: Article

References (41)

1. DS Silverberg D Wexler A Iaina, et al. 2008 The role of anaemia in patients with congestive heart failure: a short review Eur J Ht Failure 10 819 823 10.1016/j.ejheart.2008.06.015
2. JK Ghali 2009 Anemia and heart failure Curr Opin Cardiol 24 172 178 19532104 10.1097/HCO.0b013e328324ecec
3. DS Silverberg D Wexler A Palazzuoli, et al. 2009 The anemia of heart failure Acta Haematol 122 109 119 19907148 10.1159/000243795 1:CAS:528:DC%2BD1MXhsValurfM
4. ISAnemia Anand 2008 Chronic heart failure J Am Coll Cardiol 52 501 511 18687241 10.1016/j.jacc.2008.04.044
5. HF Groenwald JL Januzzi K Damman, et al. 2008 Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Cardiol 52 818 827 10.1016/j.jacc.2008.04.061
6. S-W He L-X Wang 2009 The impact of anemia on the prognosis of chronic heart failure: A meta-analysis and systemic review CHF 15 123 130 19522961
7. WH Tang W Tong A Jain, et al. 2008 Evaluation and long term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic renal failure J Am Coll Cardiol 51 569 576 18237687 10.1016/j.jacc.2007.07.094
8. G Boerrigter LC Costello-Boerrigter WT Abraham, et al. 2008 Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular function J Cardiac Failure 14 539 546 10.1016/j.cardfail. 2008.03.009
9. C Opasich M Cazzola L Scelsi, et al. 2005 Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure Eur Ht J 26 2232 2237 10.1093/eurheartj/ehi388 1:CAS:528:DC%2BD2MXht1Kku73I (Pubitemid 41541385)
10. G Weiss 2009 Iron metabolism in the anemia of chronic disease Biochim Biophys Acta 1790 682 693 18786614 1:CAS:528:DC%2BD1MXnt1yjurw%3D
11. E Nemeth 2008 Iron regulation and erythropoiesis Curr Opin Hematol 15 169 175 18391780 10.1097/MOH.0b013e3282f73335 1:CAS:528:DC%2BD1cXltlSnur8%3D (Pubitemid 351507567)
12. EA Jankowska P Rozentryt A Witkowska, et al. 2010 Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J 31 1872 1880 20570952 10.1093/eurheartj/ehq158 1:CAS:528:DC%2BC3cXpsFOitLw%3D
13. JN Nanas C Matsouka D Karageorgopoulos, et al. 2006 Etiology of anemia in patients with advanced heart failure J Am Coll Cardiol 48 2485 2489 17174186 10.1016/j.jacc.2006.08.034 (Pubitemid 44881220)
14. MT Maeder O Khammy C Dos Remedios, et al. 2010 Myocardial and systemic iron depletion in heart failure European Ht J 31 Abstract Supplement 567
15. A Besarab WA Horl D Silverberg 2009 Iron metabolism, iron deficiency, thrombocytosis and the cardiorenal anemia syndrome Oncologist 14 Suppl 1 22 33 19762514 10.1634/theoncologist.2009-S1-22 1:CAS:528:DC%2BD1MXhtlGgu77P
16. D Abramov RS Cohen SD Katz, et al. 2008 Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fraction Am J Cardiol 102 1069 1072 18929711 10.1016/j.amjcard.2008.05. 058
17. TC Hyatt RP Phadke GR Hunter, et al. 2009 Insulin sensitivity in African Americans and white women Obesity 17 276 282 19039315 1:CAS:528: DC%2BD1MXhtVWisLk%3D
18. P Van der Meer H Groenveld JL Januzzi, et al. 2009 Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 95 1309 1314 19168472 10.1136/hrt.2008.161091
19. F Tehrani P Dhesi D Daneshvar, et al. 2009 Erythropoiesis stimulating agents in heart failure patients with anemia: a metaanalysis Cardiovascular Drugs Ther 23 511 518 10.1007/s10557-009-6203-6 1:CAS:528:DC%2BC3cXjtl2htw%3D%3D
20. Ngo K, Kotecha D, Walters JA et al. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 2010 Jan 20:CD007613
21. J Ghali I Anand WT Abraham, et al. 2008 Randomized double blind trial of darbepoetin alpha treatment in patients with symptomatic heart failure and anemia Circulation 117 526 535 18195176 10.1161/CIRCULATIONAHA.107.698514 1:CAS:528:DC%2BD1cXotlCrtw%3D%3D
22. M Klapholz WT Abraham JK Ghali, et al. 2009 The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure Eur J Heart Failure 11 1071 1077 10.1093/eurjhf/hfp130 1:CAS:528:DC%2BD1MXhtlGhsLfJ
23. A Desai E Lewis S Solomon JJV McMurray M Pfeffer 2010 Impact of erythropoiesis-stimulating agents on morbidity and mortality with heart failure: an updated, post-TREAT meta-analysis Eur J Heart Failure 12 936 942 10.1093/eurjhf/hfq094
24. A Phommintikul HJ Haas M Elsik, et al. 2007 Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis Lancet 369 381 388 10.1016/S0140-6736(07)60194-9 (Pubitemid 46188479)
25. JD Rizzo MR Somerfield KL Hagerty, et al. 2008 Use of epoetin and darbepoetin in patients with cancer. American society of hematology/American society of clinical oncology clinical practice guideline update Blood 111 25 41 17954703 10.1182/blood-2007-08-109488 1:CAS:528:DC%2BD1cXjtVGltQ%3D%3D
26. MA Pfeffer EA Burdmann C-Y Chen, et al. 2009 A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease New Engl J Med 361 1 5 10.1056/NEJMoa0907845
27. SC Palmer SD Navaneethan JC Craig, et al. 2010 Meta-analysis: erythropoesis-stimulating agents in patients with chronic kidney disease Ann Int Med 153 23 33 20439566
28. LA Szczech HX Barnhart S Sapp, et al. 2010 A secondary analysis of the CHOIR study shows that comorbid conditions affect outcomes during anemia treatment Kidney Int 77 239 246 19890274 10.1038/ki.2009.415 1:CAS:528:DC%2BC3cXntVemtg%3D%3D
29. JJ McMurray IS Anand R Diaz, et al. 2009 Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF) a phase III, anaemia correction, morbidity-mortality trial Eur J Heart Fail 11 795 801 19633103 10.1093/eurjhf/hfp098 1:CAS:528:DC%2BD1MXptFCnsbY%3D
30. AK Singh 2010 ESA in dialysis patients:are you a hedgehog or a fox? J Am Soc Nephrol 21 543 545 20357173 10.1681/ASN.2010020178
31. Berns JS. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy for anemia management in dialysis patients. Curr Opin Nephrol and Hypertens 2010 (epub)
32. K Maiese F Li ZZ Chong 2005 New avenues of exploration for erythropoietin JAMA 293 90 95 15632341 10.1001/jama.293.1.90 1:CAS:528:DC%2BD2MXht1Gmtw%3D%3D (Pubitemid 40066704)
33. MO Arcasoy 2008 The non-haematopoietic biological effects of erythropoietin Brit J Haematol 141 14 31 10.1111/j.1365-2141.2008.07014.x 1:CAS:528:DC%2BD1cXltFGjsbc%3D (Pubitemid 351347536)
34. AP Bolger FP Bartlett HS Penston, et al. 2006 Intravenous iron alone for the treatment of anemia in patients with chronic heart failure J Am Coll Cardiol 48 1225 1227 16979010 10.1016/j.jacc.2006.07.015 1:CAS:528:DC%2BD28Xps1Citro%3D (Pubitemid 44345150)
35. J Toblli A Lombrana P Duarte, et al. 2007 Intravenous iron reduces NT- pro-BNP in anemic patients with chronic heart failure and renal insufficiency J Am Coll Cardiol 50 1657 1665 17950147 10.1016/j.jacc.2007.07.029 1:CAS:528:DC%2BD2sXhtF2qsr%2FP (Pubitemid 47562670)
36. RI Usmanov EB Zueva DS Silverberg 2008 Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic renal insufficiency J Nephrology 21 236 242 1:CAS:528:DC%2BD1cXht12qsrvI
37. DO Okonko A Grzeslo T Witkowski, et al. 2008 Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency J Am Coll Cardiol 51 103 112 18191732 10.1016/j.jacc.2007.09.036 1:CAS:528:DC%2BD1cXlsFeqsg%3D%3D
38. SD Anker J Comin Colet G Fillipatos, et al. 2009 Ferric Carboxymaltose in patients with heart failure and iron deficiency New Engl J Med 361 2436 2448 19920054 10.1056/NEJMoa0908355 1:CAS:528:DC%2BD1MXhsFKisr7K
39. M Matsumoto T Tsujino L-K Masaaki, et al. 2010 Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia Circulation J 74 301 306 10.1253/circj.CJ-09-0663 1:CAS:528:DC%2BC3cXitlamtb8%3D
40. F Dong X Zhang B Culver, et al. 2005 Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrosome C release: involvement of nitric oxide synthase and protein tyrosine nitration Clin Science 109 277 286 10.1042/CS20040278 1:CAS:528:DC%2BD2MXoslKgu7s%3D (Pubitemid 41337132)
41. Y Naito T Tsujino M Matsumoto, et al. 2009 Adaptive response of the heart to long term anemia induced by iron deficiency Am J Physiol Heart Circ Physiol 296 H585 H593 19136608 10.1152/ajpheart.00463.2008 1:CAS:528: DC%2BD1MXjtFGks78%3D